6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine and Duncan Disease

6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine has been researched along with Duncan Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ammann, S; Boyle, F; Cale, C; Canning, C; Dziadzio, M; Elawad, M; Fiil, BK; Grimbacher, B; Gyrd-Hansen, M; Hassan, A; Salzer, U; Speckmann, C	1

Other Studies

1 other study(ies) available for 6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine and Duncan Disease

Article	Year
Symptomatic males and female carriers in a large Caucasian kindred with XIAP deficiency. Journal of clinical immunology, 2015, Volume: 35, Issue:5 Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adult; Aged; Aged, 80 and over; Carrier State; Cells, Cultured; Child; Child, Preschool; Erythema Nodosum; Fatal Outcome; Female; Genetic Diseases, X-Linked; Humans; Inflammatory Bowel Diseases; Lymphoproliferative Disorders; Male; Middle Aged; Monocytes; Mutation; Nod2 Signaling Adaptor Protein; Pedigree; Sex Factors; Signal Transduction; Tumor Necrosis Factor-alpha; Virus Diseases; White People; X-Linked Inhibitor of Apoptosis Protein	2015

Article

Year

Symptomatic males and female carriers in a large Caucasian kindred with XIAP deficiency.

Journal of clinical immunology, 2015, Volume: 35, Issue:5

Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adult; Aged; Aged, 80 and over; Carrier State; Cells, Cultured; Child; Child, Preschool; Erythema Nodosum; Fatal Outcome; Female; Genetic Diseases, X-Linked; Humans; Inflammatory Bowel Diseases; Lymphoproliferative Disorders; Male; Middle Aged; Monocytes; Mutation; Nod2 Signaling Adaptor Protein; Pedigree; Sex Factors; Signal Transduction; Tumor Necrosis Factor-alpha; Virus Diseases; White People; X-Linked Inhibitor of Apoptosis Protein

2015